HuGE Literature Finder
Records
1
-
30
| Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes. Surgery 2022 Oct . Liu Jason B, Ramonell Kimberly M, Carty Sally E, McCoy Kelly L, Schaitkin Barry M, Karslioglu-French Esra, Morariu Elena M, Ohori N Paul, Seethala Raja R, Chiosea Simion I, Nikiforova Marina N, Nikiforov Yuri E, Yip Linw |
| Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance. Lung cancer (Amsterdam, Netherlands) 2022 Feb 166 63-69. Sun Ke, Li Meiling, Shang Mingdong, Su Xiaolian, Zhao Jiabi, Wang Bin, Wu Chunyan, Zhang Lei, Yang Shan, Sun Xiw |
| Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients. Cancer biomarkers : section A of Disease markers 2022 35 (1): 111-118. Zeng Yufei, Gao Weiqi, Chen Xiaosong, Shen Kunw |
| Outcomes after breast radiotherapy in a diverse patient cohort with a germline BRCA1/2 mutation. International journal of radiation oncology, biology, physics 2021 Oct . Chapman Bhavana V, Liu Diane, Shen Yu, Olamigoke Oluwafikayo O, Lakomy David S, Barrera Angelica M Gutierrez, Stecklein Shane R, Sawakuchi Gabriel O, Bright Scott J, Bedrosian Isabelle, Litton Jennifer K, Smith Benjamin D, Woodward Wendy A, Perkins George H, Hoffman Karen E, Stauder Michael C, Strom Eric A, Arun Banu K, Shaitelman Simona |
| Predictive factors for distant recurrence of colorectal cancer in patients after curative resection for stage I-III colorectal cancer in Australia. Langenbeck's archives of surgery 2021 Aug . Prabhakaran Swetha, Kong Joseph C, Chin Martin, Carne Peter, Farmer Chip, Skinner Stewart, Warrier Satish K, Bell Steph |
| Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy. Frontiers in oncology 2021 11 736769. Lin Po-Han, Wang Ming-Yang, Lo Chiao, Tsai Li-Wei, Yen Tzu-Chun, Huang Thomas Yoyan, Huang Wei-Chih, Yang Karen, Chen Chih-Kai, Fan Sheng-Chih, Kuo Sung-Hsin, Huang Chiun-She |
| RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients. Nuclear medicine communications 2020 Aug . Prabhu Meghana, Shakya Sunil, Ballal Sanjana, Ahmed Shamim Shamim, Bal Chandrasekh |
| Genetic 3'UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients. Scientific reports 2020 Mar 10 (1): 5736. Pamula-Pilat Jolanta, Tecza Karolina, Kalinowska-Herok Magdalena, Grzybowska E |
| Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes. Gene 2020 Feb 737 144435. Babteen Nouf Abubakr, Fawzy Manal S, Alelwani Walla, Alharbi Raed A, Alruwetei Abdulmohsen M, Toraih Eman A, Elshazli Rami |
| Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget 2019 Aug 10 (48): 4973-4986. Schroeder Cornelia, Navid-Hill Elham, Meiners Jan, Hube-Magg Claudia, Kluth Martina, Makrypidi-Fraune Georgia, Simon Ronald, Büscheck Franziska, Luebke Andreas M, Goebel Cosima, Lang Dagmar S, Weidemann Sören, Neubauer Emily, Hinsch Andrea, Jacobsen Frank, Lebok Patrick, Michl Uwe, Pehrke Dirk, Huland Hartwig, Graefen Markus, Schlomm Thorsten, Sauter Guido, Höflmayer Dor |
| DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients. Melanoma research 2019 Apr . Maric Helena, Supic Gordana, Kandolf-Sekulovic Lidija, Maric Veljko, Mijuskovic Zeljko, Radevic Tatjana, Rajovic Milica, Magic Zvon |
| RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases. Annals of surgery 2019 Jan 269 (1): 120-126. Brudvik Kristoffer W, Jones Robert P, Giuliante Felice, Shindoh Junichi, Passot Guillaume, Chung Michael H, Song Juhee, Li Liang, Dagenborg Vegar J, Fretland Åsmund A, Røsok Bård, De Rose Agostino M, Ardito Francesco, Edwin Bjørn, Panettieri Elena, Larocca Luigi M, Yamashita Suguru, Conrad Claudius, Aloia Thomas A, Poston Graeme J, Bjørnbeth Bjørn A, Vauthey Jean-Nicol |
| Multiplicity of Advanced T Category-Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma. Journal of pathology and translational medicine 2018 Nov 52 (6): 386-395. Park Hye Eun, Yoo Seungyeon, Bae Jeong Mo, Jeong Seorin, Cho Nam-Yun, Kang Gyeong Ho |
| Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast Cancers. Molecular cancer research : MCR 2018 Aug . Udyavar Akshata R, Chang Ching-Wei, Spoerke Jill M, Aimi Junko, Savage Heidi M, Daemen Anneleen, O'Shaughnessey Joyce, Bourgon Richard, Lackner Mark R, Wilson Timothy |
| Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer. BMC clinical pathology 2018 18 9. Hashmi Atif Ali, Naz Samreen, Hashmi Shumaila Kanwal, Hussain Zubaida Fida, Irfan Muhammad, Khan Erum Yousuf, Faridi Naveen, Khan Amir, Edhi Muhammad Muzzamm |
| CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study. Breast cancer research and treatment 2017 Nov 166 (1): 277-287. Hertz D L, Kidwell K M, Hilsenbeck S G, Oesterreich S, Osborne C K, Philips S, Chenault C, Hartmaier R J, Skaar T C, Sikora M J, Rae J |
| Clinicopathological Characteristics of Papillary Thyroid Cancer in Children with Emphasis on Pubertal Status and Association with BRAF Mutation. Journal of clinical research in pediatric endocrinology 2017 Sep 9 (3): 185-193. Poyrazoglu Sükran, Bundak Rüveyde, Bas Firdevs, Yegen Gülçin, Sanli Yasemin, Darendeliler Fey |
| Copy number variants in Ebstein anomaly. PloS one 2017 12 (12): e0188168. Giannakou Andreas, Sicko Robert J, Zhang Wei, Romitti Paul, Browne Marilyn L, Caggana Michele, Brody Lawrence C, Jelliffe-Pawlowski Laura, Shaw Gary M, Kay Denise M, Mills James |
| Distinct prognostic roles and heterogeneity of TTF1 copy number and TTF1 protein expression in non-small cell lung cancer. Genes, chromosomes & cancer 2017 07 56 (7): 570-581. Yoshimura Katsuhiro, Inoue Yusuke, Mori Kazutaka, Iwashita Yuji, Kahyo Tomoaki, Kawase Akikazu, Tanahashi Masayuki, Ogawa Hiroshi, Inui Naoki, Funai Kazuhito, Shinmura Kazuya, Niwa Hiroshi, Suda Takafumi, Sugimura Haruhi |
| HER2 Equivocal Status in Early Breast Cancer Is Not Associated with Higher Risk of Recurrence. Anticancer research 2016 Jul 36 (7): 3537-40. Criscitiello Carmen, Bagnardi Vincenzo, Viale Giuseppe, Disalvatore Davide, Rotmensz Nicole, Esposito Angela, Goldhirsch Aron, Curigliano Giusep |
| Validation of metabolic tumor volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery. Oral oncology 2016 Jun 57 6-14. Zhang Han, Seikaly Hadi, Nguyen Nhu-Tram, Abele Jonathan T, Dziegielewski Peter T, Harris Jeffrey R, O'Connell Daniel |
| Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations. Breast cancer research and treatment 2016 May . Lewin R, Sulkes A, Shochat T, Tsoref D, Rizel S, Liebermann N, Hendler D, Neiman V, Ben-Aharon I, Friedman E, Paluch-Shimon S, Margel D, Kedar I, Yerushalmi |
| Calcium intake, polymorphisms of the calcium-sensing receptor, and recurrent/aggressive prostate cancer. Cancer causes & control : CCC 2015 Sep . Binder Moritz, Shui Irene M, Wilson Kathryn M, Penney Kathryn L, , Mucci Lorelei A, Kibel Adam |
| CYP2D6*4 polymorphism: A new marker of response to hormonotherapy in male breast cancer? Breast (Edinburgh, Scotland) 2015 Aug 24 (4): 481-6. Abreu M H, Gomes M, Menezes F, Afonso N, Abreu P H, Medeiros R, Pereira D, Lopes |
| Chromosomal instability as a prognostic marker in cervical cancer. BMC cancer 2015 15 (1): 361. How Christine, Bruce Jeff, So Jonathan, Pintilie Melania, Haibe-Kains Benjamin, Hui Angela, Clarke Blaise A, Hedley David W, Hill Richard P, Milosevic Michael, Fyles Anthony, Liu Fei-F |
| The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors. PloS one 2015 10 (7): e0132821. Czarniecka Agnieszka, Kowal Monika, Rusinek Dagmara, Krajewska Jolanta, Jarzab Michal, Stobiecka Ewa, Chmielik Ewa, Zembala-Nozynska Ewa, Poltorak Stanislaw, Sacher Aleksander, Maciejewski Adam, Zebracka-Gala Jadwiga, Lange Dariusz, Oczko-Wojciechowska Malgorzata, Handkiewicz-Junak Daria, Jarzab Barba |
| Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer. Breast cancer research and treatment 2014 Aug 147 (1): 211-9. Arthur L M, Turnbull A K, Renshaw L, Keys J, Thomas J S, Wilson T R, Lackner M R, Sims A H, Dixon J |
| Mutation profile of differentiated thyroid tumours in an Australian urban population. Internal medicine journal 2014 Aug 44 (8): 727-34. Mond M, Alexiadis M, Fuller P J, Gilfillan |
| The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients. Breast cancer research and treatment 2013 Jul 140 (1): 83-92. Stemmer Salomon M, Klang Shmuel H, Ben-Baruch Noa, Geffen David B, Steiner Mariana, Soussan-Gutman Lior, Merling Shahar, Svedman Christer, Rizel Shulamith, Lieberman Nic |
| CYP2C19 2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment. Breast cancer research and treatment 2013 Jun 139 (3): 3. Beelen K, Opdam M, Severson TM, Koornstra RH, Vincent AD, Hauptmann M, van Schaik RH, Berns EM, Vermorken JB, van Diest PJ, Linn SC |
- Page last reviewed:Jul 25, 2022
- Page last updated:Dec 02, 2022
- Content source: